Collective Molecular Activities of the Plant: Carpesium Faberi
Example Image
PLANiTS DNA barcode
Taxonomic Information
Plant ID: NPO23499
Plant Latin Name: Carpesium Faberi
Taxonomy Genus: Carpesium
Taxonomy Family: Asteraceae
Plant External Links:
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
65 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
52 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
50 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC90014
Ingredient ID: NPC85813
Ingredient ID: NPC7965
Ingredient ID: NPC75844
Ingredient ID: NPC71639
Ingredient ID: NPC67508
Ingredient ID: NPC62290
Ingredient ID: NPC57788
Ingredient ID: NPC56593
Ingredient ID: NPC54321
Ingredient ID: NPC54145
Ingredient ID: NPC51700
Ingredient ID: NPC49168
Ingredient ID: NPC47844
Ingredient ID: NPC470014
Ingredient ID: NPC470013
Ingredient ID: NPC470012
Ingredient ID: NPC470011
Ingredient ID: NPC470010
Ingredient ID: NPC470009
Ingredient ID: NPC43276
Ingredient ID: NPC41163
Ingredient ID: NPC37607
Ingredient ID: NPC34429
Ingredient ID: NPC323008
Ingredient ID: NPC310562
Ingredient ID: NPC290508
Ingredient ID: NPC282974
Ingredient ID: NPC282694
Ingredient ID: NPC27532
Ingredient ID: NPC274613
Ingredient ID: NPC273326
Ingredient ID: NPC26960
Ingredient ID: NPC264317
Ingredient ID: NPC262133
Ingredient ID: NPC254199
Ingredient ID: NPC244705
Ingredient ID: NPC243728
Ingredient ID: NPC242580
Ingredient ID: NPC230920
Ingredient ID: NPC230301
Ingredient ID: NPC22098
Ingredient ID: NPC219011
Ingredient ID: NPC215242
Ingredient ID: NPC210560
Ingredient ID: NPC201048
Ingredient ID: NPC194208
Ingredient ID: NPC1940
Ingredient ID: NPC192744
Ingredient ID: NPC181225
Ingredient ID: NPC178134
Ingredient ID: NPC171928
Ingredient ID: NPC165651
Ingredient ID: NPC155935
Ingredient ID: NPC149203
Ingredient ID: NPC147272
Ingredient ID: NPC143799
Ingredient ID: NPC138408
Ingredient ID: NPC125575
Ingredient ID: NPC123965
Ingredient ID: NPC123658
Ingredient ID: NPC116620
Ingredient ID: NPC110899
Ingredient ID: NPC106200
Ingredient ID: NPC101475
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Therapeutic Target | Enzyme | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
| Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
| Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
| Therapeutic Target | Enzyme | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
| Therapeutic Target | Enzyme | AKR1C3 | Aldo-keto-reductase family 1 member C3 | P42330 | CHEMBL4681 |
| Therapeutic Target | Enzyme | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
| Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
| Therapeutic Target | Other cytosolic protein | HSPA1A | Heat shock 70 kDa protein 1 | P0DMV8 | CHEMBL5460 |
| Therapeutic Target | Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
| Therapeutic Target | Oxidoreductase | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
| Therapeutic Target | Oxidoreductase | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
| Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
| Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
| Therapeutic Target | Protein Kinase | TEK | Tyrosine-protein kinase TIE-2 | Q02763 | CHEMBL4128 |
| Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
| Therapeutic Target | Protein Kinase | SRC | Tyrosine-protein kinase SRC | P12931 | CHEMBL267 |
| Therapeutic Target | Protein Kinase | NUAK1 | NUAK family SNF1-like kinase 1 | O60285 | CHEMBL5784 |
| Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
| Therapeutic Target | Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
| Therapeutic Target | Protein Kinase | INSR | Insulin receptor | P06213 | CHEMBL1981 |
| Therapeutic Target | Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
| Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
| Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
| Drug Transporter | SLC superfamily of solute carriers | SLC22A6 | Solute carrier family 22 member 6 | Q4U2R8 | CHEMBL1641347 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | GPR35 | G-protein coupled receptor 35 | Q9HC97 | CHEMBL1293267 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
| Therapeutic Target | Transcription factor | SMAD3 | Mothers against decapentaplegic homolog 3 | P84022 | CHEMBL1293258 |
| Therapeutic Target | Transcription factor | RELA | Nuclear factor NF-kappa-B p65 subunit | Q04206 | CHEMBL5533 |
| Therapeutic Target | Transferase | POLH | DNA polymerase eta | Q9Y253 | CHEMBL5542 |
| Therapeutic Target | Transferase | GSTP1 | Glutathione S-transferase Pi | P09211 | CHEMBL3902 |
| Therapeutic Target | Transferase | POLI | DNA polymerase iota | Q9UNA4 | CHEMBL5391 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 1228 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | mucinous carcinoma;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00384878 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05135364 | HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02023593 | FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00963729 | Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01338558 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04379596 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03) | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03037541 | Cryosurgery and Cream Combination for Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT05476432 | HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | peritoneum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02676349 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00551759 | Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT02485548 | Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03764553 | Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
| NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT05108428 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02590367 | Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | peripheral neuropathy | Fluorouracil (NPC75844) | NP level |
| NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02885753 | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00083109 | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | renal cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00940303 | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01652976 | Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
| NCT00023868 | Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04793932 | Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01332604 | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | biliary tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02047201 | Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05229497 | FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00006786 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | bladder tumor | Fluorouracil (NPC75844) | NP level |
| NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00029679 | Borage Oil and Ginkgo Biloba (EGb 761) in Asthma | asthma | Linoleic Acid (NPC85813) | NP level |
| NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | dysplasia of cervix | Fluorouracil (NPC75844) | NP level |
| NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03326947 | Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03189719 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00665392 | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04927780 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03675737 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04185883 | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02482441 | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02383966 | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01896531 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05132504 | Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02142322 | Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | chronic myeloproliferative disorder;multiple myeloma;myelodysplastic syndrome | Fluorouracil (NPC75844) | NP level |
| NCT04752696 | Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03168607 | Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
| NCT03484299 | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006115 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | cervical cancer | Fluorouracil (NPC75844) | NP level |
| NCT00498953 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00592501 | Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT05024097 | A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00015886 | Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00468169 | Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03109158 | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02241551 | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03386838 | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03484195 | Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00066274 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
| NCT00943137 | The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02468557 | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT04769414 | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04161755 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00166465 | Stage IV Colorectal CA ALIMTA | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03368859 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | cancer | Fluorouracil (NPC75844) | NP level |
| NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02019355 | Actinic Keratosis Study | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04151277 | PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00016952 | Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00601627 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05348811 | HAIC Combined With Donafenib and Sintilimab for Unresectable ICC | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00797485 | Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00296608 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02704520 | Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00615056 | A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00995293 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04488159 | Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03197584 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03443492 | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04510064 | PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03577704 | The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01821729 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | uterine neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00008060 | Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02246049 | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01269229 | A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02767219 | The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery | glaucoma | Fluorouracil (NPC75844) | NP level |
| NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03197571 | QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | urothelial carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03387592 | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04217954 | HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | peritoneal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00091312 | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00261703 | Docetaxel in Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | cancer | Fluorouracil (NPC75844) | NP level |
| NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01836432 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003063 | Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00499850 | Phase I FOLFOX Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Ellagic Acid (NPC178134) | NP level |
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | laryngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03574649 | QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma;metastasis | Fluorouracil (NPC75844) | NP level |
| NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03167164 | QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
| NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | colorectal neoplasm;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01528618 | Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01522989 | PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05179889 | Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02494583 | Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00193219 | Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT05319639 | Phase I Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03861702 | Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02281682 | IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
| NCT02648425 | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT05065801 | Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00607945 | Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Linoleic Acid (NPC85813) | NP level |
| NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
| NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer | Fluorouracil (NPC75844) | NP level |
| NCT00379262 | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01171482 | Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05493332 | HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03783442 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | esophageal carcinoma;stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03426904 | Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03443661 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00393068 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04393298 | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04919226 | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03306121 | TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02319018 | Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors | digestive system cancer | Fluorouracil (NPC75844) | NP level |
| NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00274937 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05268510 | Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03428529 | Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02959879 | Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma | anal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04749108 | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT03391843 | Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT05469061 | Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00696488 | Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT00270543 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03370406 | Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05253846 | Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03991962 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02884128 | A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02115152 | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00525759 | Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03300544 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03110926 | Induction Chemotherapy for Locally Advanced Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03727061 | Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | head and neck carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT05446467 | Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006051 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03487016 | First-line Therapy in Metastatic PDAC | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02842580 | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03143153 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00098787 | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01633970 | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00988897 | Colorectal Cancer RECHALLENGE | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05235542 | A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00954512 | Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01542931 | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00075595 | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03042780 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | pancreatic endocrine carcinoma;pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00427570 | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Fluorouracil (NPC75844) | NP level |
| NCT00002999 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00324415 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05472259 | A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02319304 | Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT05078827 | Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02289768 | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT05433597 | A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02337933 | Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome | metabolic syndrome | Ursolic Acid (NPC51700) | NP level |
| NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02672917 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | melanoma | Betulinic Acid (NPC264317) | NP level |
| NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | cancer | Fluorouracil (NPC75844) | NP level |
| NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT03563144 | QUILT-3.088: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
| NCT00463840 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | digestive system cancer | Fluorouracil (NPC75844) | NP level |
| NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04480190 | Neoadjuvant Therapy in Biliary Adenocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00005979 | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02580253 | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02375672 | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00006468 | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT00112697 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03671252 | Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04170530 | Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01836653 | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | anal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03300609 | 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01274962 | A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
| NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Fluorouracil (NPC75844) | NP level |
| NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | gastrointestinal stromal tumor;esophageal cancer;gastric cancer;pancreatic carcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02291289 | A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01953406 | The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05314998 | Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02648711 | Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03136406 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00983541 | Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | cancer | Fluorouracil (NPC75844) | NP level |
| NCT04292743 | Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006103 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT04149015 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00611507 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT05217069 | A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01374425 | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00865189 | A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02967887 | Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00021398 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | liver cancer | Fluorouracil (NPC75844) | NP level |
| NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03484221 | Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02358031 | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00497497 | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00188877 | Intensity Modulated Radiation Therapy for Head and Neck Cancer | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01653470 | Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens | cancer | Fluorouracil (NPC75844) | NP level |
| NCT02459457 | A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05052099 | Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT05251038 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04228601 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02817113 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01217060 | Trimodality Management of T1b Esophageal Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT05466799 | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00217737 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | Lynch syndrome;signet ring cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04523818 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | lymphoma | Fluorouracil (NPC75844) | NP level |
| NCT03387085 | QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00045747 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03216876 | A Study Of Ursolic Acid For Primary Sclerosing Cholangitis | sclerosing cholangitis | Ursolic Acid (NPC51700) | NP level |
| NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02591030 | Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours | bile duct cancer | Fluorouracil (NPC75844) | NP level |
| NCT02268695 | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00145769 | A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02681003 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01750918 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00467142 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04722133 | Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT01472016 | Study of ABT-700 in Subjects With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) | hypopharyngeal carcinoma;laryngeal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03387098 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00212589 | Patients Preference for Oral or i.v. Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT02830139 | Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT04839731 | Combination 5-FU / Calcipotriene Cream for SCCIS/SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01333709 | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03586869 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03748134 | Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03771846 | HAIC Versus Systemic Chemotherapy for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00992199 | Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00265811 | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
| NCT00807911 | Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002525 | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04854499 | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Fluorouracil (NPC75844) | NP level |
| NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT05083247 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01802645 | Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02551991 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002498 | Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04937738 | Perioperative Chemotherapy in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04757363 | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT02246127 | Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02400567 | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02588105 | Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03780049 | HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00303628 | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05239741 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT03340896 | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03605706 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01142414 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
| NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis;neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01418222 | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04325425 | Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT00346502 | Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) | dysplastic nevus | Betulinic Acid (NPC264317) | NP level |
| NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05035381 | PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00278694 | Oxaliplatin and 5-FU Based Preoperative Chemoradiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00721513 | Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00460265 | Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00006366 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04495088 | Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04962958 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00454116 | A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04229459 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04821284 | Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01047293 | RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04420884 | A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00710736 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00500292 | A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004257 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT02921256 | Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04550260 | Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01490866 | A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01498783 | Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma | central nervous system cancer;ependymoma | Fluorouracil (NPC75844) | NP level |
| NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00630032 | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00544414 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03329248 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01465451 | Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02063802 | Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | obesity | Linoleic Acid (NPC85813) | NP level |
| NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04003792 | Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02720068 | Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00951158 | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | neoplasm | Linoleic Acid (NPC85813) | NP level |
| NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT02456714 | Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00413322 | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01289821 | First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00080951 | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00046995 | Combination Chemotherapy in Treating Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00967616 | Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02244632 | Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003994 | Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
| NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03760614 | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003298 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | anal neoplasm;squamous cell intraepithelial neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | lymphoma | Fluorouracil (NPC75844) | NP level |
| NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01081041 | A Study in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03085914 | A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02141295 | A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02969473 | Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Fluorouracil (NPC75844) | NP level |
| NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03323463 | Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma | oropharynx squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03250832 | Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00357149 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02041481 | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00199797 | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01324141 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT02021422 | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01362374 | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03067792 | FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02172976 | Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00449137 | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03487939 | Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
| NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03130790 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04004871 | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02640365 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT04994236 | Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03175666 | QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00556413 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | colorectal adenocarcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02937116 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
| NCT05214339 | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00081289 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04011618 | Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | metabolic syndrome | Ellagic Acid (NPC178134) | NP level |
| NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | basal cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002888 | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04832776 | FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00423696 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02028806 | mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04356170 | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00507091 | Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02534337 | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01525329 | Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT04807972 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04949256 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04589234 | Saltikva for Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01704703 | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00541112 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02225652 | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01047007 | A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04675983 | A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00642577 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03554109 | QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00210184 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00335816 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01524094 | Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02405585 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00778102 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03837977 | Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05329766 | A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | breast cancer | Linoleic Acid (NPC85813) | NP level |
| NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04127019 | Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00719199 | Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01383343 | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05047991 | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01354717 | Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo | actinic keratosis | Fluorouracil (NPC75844) | NP level |
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00526110 | Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
| NCT02887313 | FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT00237900 | Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00832299 | Neo-Adjuvant FOLFOX for Rectal Carcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01442935 | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01591135 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00671372 | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00999700 | Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00436267 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02795988 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00003627 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | liver cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Fluorouracil (NPC75844) | NP level |
| NCT02506842 | Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00204932 | Effects of CLA Supplements on Body Weight and Fat Oxidation | obesity | Linoleic Acid (NPC85813) | NP level |
| NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01348217 | Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
| NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00628810 | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02508077 | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04437329 | Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03358472 | Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | kidney cancer | Fluorouracil (NPC75844) | NP level |
| NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | laryngeal neoplasm;oral cavity cancer;paranasal sinus neoplasm;pharynx cancer | Fluorouracil (NPC75844) | NP level |
| NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03421353 | AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | esophageal carcinoma;stomach neoplasm;adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01914900 | Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02217020 | Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03736720 | Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin | pancreatic endocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02514278 | Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00541125 | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02715531 | A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01572324 | Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT04176952 | PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05024513 | Biliary Drainage Plus HAIC in Locally Advanced pCCA | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04611724 | Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00268372 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00041262 | Combination Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;renal cell carcinoma;non-small cell lung carcinoma;ovarian carcinoma;breast carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT05015621 | A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04834206 | Nedaplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01181401 | InductionChemo-Radio-Antibody-Treatment | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02025023 | Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study | meibomian cyst | Fluorouracil (NPC75844) | NP level |
| NCT02359968 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01787006 | Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00478946 | A Study of Picoplatin in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00268333 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT02369939 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | anal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03169764 | QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03504423 | Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01383707 | A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00202774 | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03600623 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | skin carcinoma;squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05171166 | Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01099358 | Study in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01871571 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04390399 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00062426 | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00016198 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01302613 | Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02440958 | Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03082209 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
| NCT02625610 | Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00025090 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002692 | Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03092895 | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
| NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT01765582 | Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | thrombotic disease;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02017600 | A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05332002 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003260 | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002884 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002896 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00571740 | Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00208936 | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
| NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04120701 | CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT05033522 | Immunotherapy for Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04481204 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03387111 | QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00002793 | Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00000122 | Fluorouracil Filtering Surgery Study (FFSS) | glaucoma | Fluorouracil (NPC75844) | NP level |
| NCT05166772 | Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003777 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00002883 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04990037 | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03781323 | Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03869034 | HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
| NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00089024 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01126216 | Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
| NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01013805 | Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02967289 | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03048123 | HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00070213 | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01167725 | Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03002064 | Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03722498 | Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00316888 | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT05221658 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00747799 | Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03881111 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | prostate cancer | Ursolic Acid (NPC51700) | NP level |
| NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT04469556 | Pancreatic Adenocarcinoma Signature Stratification for Treatment | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03524508 | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
| NCT00952029 | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03941093 | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | cancer | Fluorouracil (NPC75844) | NP level |
| NCT05193292 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04354662 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
| NCT00349076 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04755543 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00103103 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01489865 | ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01946074 | A Study of ABT-165 in Subjects With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003446 | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02071069 | Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT04089150 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
| NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00006472 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01941641 | Colon Neoadjuvant FOLFOXIRI Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04370418 | A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | cancer | Fluorouracil (NPC75844) | NP level |
| NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT04164238 | Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
| NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00003422 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02024607 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | cancer | Fluorouracil (NPC75844) | NP level |
| NCT00069121 | A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02941562 | A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02973685 | HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00002893 | Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03641976 | A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00009737 | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02820857 | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03548961 | Organ Preservation in Early Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01442649 | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01566435 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
| NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | esophageal carcinoma;gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00303771 | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
| NCT03806309 | Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00003018 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
| NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01233843 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00813137 | FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
| NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT02393833 | IBCSG Trial 22-00 Serum Substudy | breast cancer | Fluorouracil (NPC75844) | NP level |
| NCT00066846 | Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
| NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
| NCT03169738 | QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT02641691,NCT00308516,NCT01804790,NCT04703101,NCT02000050,NCT01383343,NCT01333709,NCT00068692,NCT04749108
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT00595972,NCT00149201,NCT03067792,NCT00384878,NCT02563054,NCT00343239,NCT00002722,NCT01286766,NCT02486601,NCT02934464,NCT05319639,NCT01285557,NCT00857246,NCT03825861,NCT01662869,NCT03130790,NCT00103103,NCT00313872,NCT00052910,NCT00374036,NCT01896531,NCT00003298,NCT00202969,NCT03606928,NCT00525785,NCT00020787,NCT03015675,NCT00992199,NCT03694522,NCT02442362,NCT00941655,NCT00447967,NCT02574663,NCT03675737,NCT01283204,NCT00711243,NCT00005060,NCT01590719,NCT04358354,NCT00003862,NCT04393584,NCT00811447,NCT00210184,NCT00054873,NCT03939962,NCT04757363,NCT00514020,NCT01183559,NCT01198392,NCT01889303,NCT02578368,NCT04379596,NCT01851941,NCT00976768,NCT04155671,NCT00002783,NCT04859582,NCT01924819,NCT00400179,NCT00155883,NCT00004233,NCT00003172,NCT00004873,NCT00611507,NCT00002615,NCT01769508,NCT02845908,NCT00270543,NCT01041404,NCT03607656,NCT04358341,NCT01216644,NCT00123318,NCT04149015,NCT00002883,NCT00188266,NCT02142322,NCT01503372,NCT02296671,NCT04997837,NCT02114359,NCT04937738,NCT00142350,NCT01774786,NCT00555672,NCT04354662,NCT00004099,NCT00215514
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GALNT2,AKR1B1,HSD17B10,ACHE,HPGD,FFAR4,ALOX15,APEX1
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT00126256,NCT02419495,NCT00289445,NCT00374036,NCT02124148,NCT00065117,NCT00149201
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
ACHE,FFAR4,MET,GPR35,TSHR,F2,FFAR4
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
THPO,KDM4E,ACHE,GPR35,HPGD,ELAVL3,ALOX15
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT01608464,NCT00209690,NCT01843049,NCT00069953,NCT03281369,NCT00008047,NCT00425425,NCT01348217,NCT03910634,NCT00004897,NCT00021320,NCT00551759,NCT01372202,NCT00020787,NCT00258323,NCT00193141,NCT00735345,NCT00193882,NCT00160030,NCT00861094,NCT00054873,NCT00525915,NCT00632333,NCT00041262,NCT00075738,NCT00086996,NCT01611857,NCT00002631,NCT00759226,NCT01217060,NCT02735239,NCT00052910,NCT00002984,NCT02574663,NCT00544362,NCT00209716,NCT02359968,NCT00381706,NCT00539617,NCT03881111,NCT00259402,NCT01998347,NCT03110926,NCT00004257,NCT00006472,NCT00004233,NCT03002064,NCT02023593,NCT01183559,NCT00393068,NCT00002883,NCT00002884,NCT00002897,NCT00570531,NCT00047112,NCT00915850,NCT00733889,NCT00003118,NCT01787006,NCT01704690,NCT00416858,NCT03764553,NCT03189719,NCT03279237,NCT00230451
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00261703,NCT03326947,NCT00080990,NCT00021073,NCT04176952,NCT00413322,NCT04541108,NCT04420884,NCT02588105,NCT00357149,NCT00004913,NCT02648711,NCT00502567,NCT00995293,NCT02817113,NCT00215501,NCT04185883,NCT04047862,NCT00402545,NCT01047007,NCT03577704,NCT01930552,NCT02723955,NCT04607421,NCT01522989,NCT00020488,NCT00004242,NCT01206465,NCT00954512,NCT00044785,NCT04393298,NCT00610948,NCT00024141,NCT03085914,NCT02648425,NCT01566435,NCT01946074,NCT03421353,NCT03503604,NCT04151277,NCT01099358,NCT02715531,NCT00005068,NCT03250832,NCT00043121,NCT00811993,NCT00004059,NCT01472016,NCT00448136,NCT02884128,NCT00246103,NCT00007878,NCT00951158,NCT00042861,NCT00289445,NCT00005791,NCT00042874,NCT02720068,NCT00838370,NCT01362374,NCT01634555,NCT02482441
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
KDR,MET,EGFR
NCT03169738,NCT03574649,NCT02419495 |
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
GSTP1,IGF1R,RORC,MET,EGFR,KDR
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00003642,NCT00006111,NCT00055601,NCT00003175,NCT00024349,NCT00981656
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
LMNA,SRC,ACHE,GSTP1,FABP3,INSR
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
THPO,AKR1C3,ACHE,GPR35,TSHR,F2
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
MET,EGFR,KDR
NCT00002747,NCT01126216,NCT00665392,NCT03358472,NCT00004094,NCT00003637,NCT00093665,NCT00002999,NCT00003777,NCT00203905,NCT03727061,NCT00002888,NCT00002735,NCT00002476,NCT00004164,NCT00268372,NCT00004865,NCT02997332,NCT00003627,NCT00721513,NCT01467115,NCT00054054,NCT00004097,NCT00498953,NCT00002839,NCT00004901,NCT03342352,NCT00004089,NCT00352105,NCT04428333,NCT00460265,NCT00003888,NCT02353260,NCT00095875,NCT00006051,NCT00002496,NCT00193284,NCT00544414,NCT00392704,NCT03386838,NCT00003576,NCT00608205,NCT01081041,NCT02358031,NCT00868491,NCT00006248,NCT00052429,NCT04356170,NCT00122460,NCT00646659,NCT00468169,NCT01142414,NCT00113399,NCT02741570,NCT00352118,NCT01911598 |
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT05135364,NCT01327521,NCT00849264,NCT00921531,NCT05493332,NCT05166772,NCT05029973,NCT05171166,NCT02580253,NCT00933816,NCT02452853,NCT02967887,NCT03605706,NCT03780634,NCT04994236,NCT03192618,NCT03468231,NCT02534337,NCT05214339,NCT05033522,NCT02527772,NCT04962958,NCT03780049,NCT02981498,NCT03812783,NCT01953406,NCT02767375,NCT05263219,NCT05476432,NCT00143403,NCT02755311,NCT02069041,NCT02987699,NCT03469479,NCT00559455,NCT02426450,NCT02774187,NCT03812770,NCT03869034,NCT00471965,NCT01775501,NCT01055743,NCT01171482,NCT00619541,NCT03722498,NCT02973685,NCT03803254,NCT03563170,NCT03192644,NCT03048123
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
INSR,MET,KDR,ACHE,MAOA
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MET,KDR,EGFR
NCT00083109,NCT02419495 |
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
MET,HSPA1A,EGFR,KDR,HSPA1B
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
KDR,MET,SRC
NCT00004206,NCT03197584 |
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
SRC,IGF1R,KDR,INSR
NCT00003331 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
RELA,FFAR1,INSR,F2
NCT00607945 |
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
AKR1B1,ACHE,MET
NCT00000122,NCT02767219 |
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
NCT04755543,NCT01434069,NCT02319018,NCT03800693 |
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
KDR,EGFR,MET
NCT03167177,NCT00701987 |
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT04480190,NCT02456714,NCT05348811,NCT03603834,NCT05024513
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT05083247,NCT00417209,NCT01121848,NCT01413022,NCT00220649
|
Malignant neoplasms of stomach, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.Z |
NCT02048540,NCT00237900,NCT03081143,NCT00509964,NCT01748851
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT00429299,NCT00174707,NCT01779050,NCT00121992,NCT01220128
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
SLC22A6,GPR35,AKR1C3,SRC,AKR1C3
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LMNA,POLH,TSHR,KDR,MET
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
HSPA1B,KDR,SRC,HSPA1A
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
MET,SRC,KDR,EGFR
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
EGFR,KDR,GSTP1
NCT00003331 |
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
GSTP1,EGFR,SRC,IGF1R
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
IGF1R,AKR1B1,INSR,ACHE
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
MET,F2,SRC,KDR
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
FFAR1,KDR,AKR1B1,INSR
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC
NCT00023660,NCT00003209,NCT00003078 |
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
SRC,IGF1R,HSPA1A,HSPA1B
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
SRC,RORC,RELA,F2
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
SRC,KDR
NCT00001569,NCT00352755 |
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
NCT04502641,NCT01312350,NCT00508664 |
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00003585,NCT00003664,NCT00053807,NCT00053820
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
ALOX15,HSPA1A,ACHE
NCT02969473 |
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
RORC,ACHE,ELAVL3,MET
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
IGF1R,GSTP1,FABP3,FFAR1
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,EGFR,FFAR1,GPR35
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
HPGD,FABP3,FFAR1,MET
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT01198548,NCT00003873,NCT05179889,NCT04303429,NCT00079274,NCT02041481,NCT03641976,NCT00070122,NCT01383343,NCT04120701,NCT00309530,NCT03426904,NCT01238965,NCT02510118,NCT02138617,NCT00337389,NCT04003792,NCT05174169,NCT00309543,NCT00499369,NCT00235898,NCT01111604,NCT04259944,NCT00101894,NCT00646607,NCT04488159,NCT05062889,NCT00004931,NCT00003835,NCT01205022,NCT01347645,NCT02967289,NCT00942266,NCT01270438,NCT03883802,NCT04832776,NCT00193219,NCT00025337
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT04949256,NCT01248299,NCT03109158,NCT02459457,NCT05221658,NCT05213312,NCT04229459,NCT03783442,NCT01225523,NCT05125055,NCT01914900,NCT03732508,NCT01627379,NCT03748134,NCT03224221,NCT05469061,NCT01391572,NCT02485548,NCT02017600,NCT04926753,NCT00705016,NCT02325986,NCT04649476,NCT04460352,NCT02218164,NCT04550260,NCT01542931,NCT04839731,NCT03387111,NCT01836029,NCT03370406,NCT01181401,NCT01591135,NCT02383966
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01526135,NCT02440958,NCT02468557,NCT04292743,NCT03970252,NCT00054873,NCT02795988,NCT00548548,NCT04793932,NCT02959879,NCT05314998,NCT01676259,NCT04752696,NCT00307723,NCT05209074,NCT04469556,NCT03331640,NCT04821284,NCT04990037,NCT02243007,NCT05472259,NCT03806309,NCT05257993,NCT04539808,NCT04481204,NCT02178709,NCT04927780,NCT05132504,NCT01893294,NCT03977233
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
HSPA1A,EGFR,HSPA1B
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MET,SRC,KDR
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
NCT00003175,NCT00006111 |
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
AKR1B1,HSPA1A,HSPA1B
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
EGFR
NCT00001579,NCT00003956 |
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
IGF1R,APEX1,TEK
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MET,KDR,EGFR
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
KDR,SRC
NCT02574663 |
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
MET,CES1,TEK
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
HSPA1A,HSPA1B,SMAD3
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
HSPA1A,HSPA1B,SRC
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
KDR,MET,TSHR
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MAOA,AKR1C3
NCT04403568 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
ACHE,SRC,MAOA
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
AKR1C3,TSHR,F2
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
GPR35,F2,ALOX15
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
HPGD,FFAR4,POLH
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FFAR1,MET,GPR35
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
THPO,SMAD3,FFAR4
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT02413853,NCT01383343,NCT01277406,NCT04094688,NCT00079274,NCT00166465,NCT03069950,NCT00942266,NCT00387387,NCT02071069,NCT00707889,NCT00070122,NCT01704703,NCT03050814,NCT02508077,NCT02355379,NCT00851045,NCT04068103,NCT00507091,NCT01605344,NCT00096278,NCT01862003,NCT03300609,NCT00003873,NCT00499850,NCT00025337,NCT00967616,NCT01270438,NCT00003835
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT00817583,NCT00697905,NCT02500940,NCT00188877,NCT02434614,NCT03574324,NCT00816855,NCT03503136,NCT03175939,NCT04004871,NCT00592501,NCT00677118,NCT04437329,NCT00201396,NCT02016417,NCT01245959,NCT02012062,NCT03604965,NCT04834206,NCT05433597,NCT01528618,NCT03020329,NCT01536223,NCT02590133,NCT00379262,NCT00816816,NCT03306121,NCT00747799,NCT03668730
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT03368859,NCT01750918,NCT02024607,NCT05329766,NCT00943137,NCT05229497,NCT00500292,NCT02640365,NCT01332604,NCT01183663,NCT00479583,NCT03143153,NCT01046864,NCT01653470,NCT05217069,NCT00983541,NCT05332002,NCT05235542,NCT01633970,NCT03082209,NCT00710736,NCT04611724,NCT02937116,NCT00941499,NCT04370418
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
GSTP1,EGFR,MET,IGF1R,KDR
NCT01263171,NCT00009737,NCT00001428,NCT00786643,NCT00551213,NCT00070434,NCT00066846,NCT00002793,NCT00004885,NCT00284258,NCT01628211,NCT01765582,NCT00537823,NCT01193452,NCT01338558,NCT00354978,NCT00335816,NCT00003063,NCT00454116,NCT01289821,NCT01442935,NCT00613080,NCT00005979,NCT00002525,NCT01736904,NCT00058474,NCT00615056,NCT00280176,NCT02415699,NCT00075595,NCT01652482,NCT02515734,NCT01167725,NCT00202787,NCT00296608,NCT00098787,NCT00027833,NCT00755118,NCT00265811,NCT01622543,NCT00209703,NCT05193292,NCT00002896,NCT01276379,NCT02124148,NCT00002523,NCT01068132,NCT00126256,NCT00278889,NCT00016133,NCT00005050,NCT02885753,NCT00349336,NCT00628810,NCT01326000,NCT00143403,NCT00008281,NCT01077739,NCT00006037,NCT00388700,NCT00039208,NCT00321828,NCT01286818,NCT00182715,NCT00006103,NCT01133990,NCT01279681,NCT00988897,NCT00449137,NCT00952029,NCT00378716,NCT00046995,NCT00002593,NCT02244632,NCT00004150,NCT00265850,NCT00006015,NCT02384850,NCT00091312,NCT00291785,NCT00006366,NCT01205711,NCT00889343,NCT00813137,NCT00003446,NCT05081687,NCT00069108,NCT00268398,NCT00008060,NCT01374425,NCT01227707,NCT00268333,NCT01529164,NCT00642577,NCT00423696,NCT01183780,NCT00002692,NCT01047293,NCT02842580,NCT00212589,NCT00003543,NCT00026364,NCT00541112,NCT00023868,NCT01479465,NCT00004252,NCT00274872,NCT00006468,NCT01383707,NCT00061815,NCT00003001,NCT02376452,NCT00006786,NCT00958737,NCT00720512,NCT02830139,NCT00016978,NCT00006115,NCT00839111,NCT00303771,NCT00336960,NCT00005586,NCT00025142,NCT01490866,NCT01417494,NCT00021398,NCT00873275,NCT02826837,NCT00004102,NCT00501410,NCT00118261,NCT01150045,NCT00069095,NCT00559741,NCT00176774,NCT02246049,NCT00016952,NCT02494973,NCT00098982,NCT00425152,NCT00081289,NCT00719199,NCT00049101,NCT01465451,NCT01478594,NCT00640081,NCT01802645,NCT00020501,NCT00112918,NCT00199797,NCT00003594,NCT00862784,NCT00003254,NCT05239741,NCT00778102,NCT00721916,NCT00571740,NCT00069121,NCT00884767,NCT00065117,NCT00323011,NCT02291289,NCT00467142,NCT00427570,NCT00003260,NCT00003287,NCT00973609,NCT00023751,NCT00940303,NCT04337879,NCT03487939,NCT00797485,NCT00385021,NCT00209625,NCT00002551,NCT00026273,NCT00577109,NCT00111761,NCT00080951,NCT00055822,NCT00085163,NCT01718873,NCT00070213,NCT00647530,NCT00831181,NCT01418222,NCT01679327,NCT05035381,NCT01515787,NCT05253651,NCT00004005,NCT00427310,NCT00062426,NCT00002570,NCT00609622,NCT00006479,NCT00021281,NCT00556413,NCT00202774,NCT00066274,NCT00003422,NCT00002828,NCT00077233,NCT00286000,NCT00544011,NCT00866944,NCT00384176,NCT00671372,NCT02141295,NCT01442649,NCT00749450,NCT00002893,NCT00497497,NCT00469443,NCT01836653,NCT00110721,NCT00064181,NCT00541125,NCT00478946,NCT00612586,NCT00262808,NCT00016198,NCT01226719,NCT00020917,NCT00072553,NCT00002716,NCT00719797,NCT02375672,NCT01375816,NCT01271166 |
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
AKR1C3,F2
NCT00002774,NCT03340896,NCT00274937,NCT04854499,NCT03169764,NCT01233843,NCT04164238,NCT05446467,NCT00971932,NCT00139269,NCT01086826,NCT03855384,NCT02268695,NCT01154920,NCT02551159,NCT02047201,NCT00513383,NCT01177956,NCT00736944,NCT00999700 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
RECQL,THPO,HSD17B10,EGFR,ACHE,TSHR,APEX1,MET,LMNA,TDP1,AKR1B1,GSTP1,KDR,FABP3,SRC,CSNK2A2,SMN1,CSNK2A1,NUAK1,TEK,FFAR1,POLH
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
RELA,SRC
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
MET,EGFR
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN2,SMN1
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
F2,AKR1B1
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
RELA,INSR
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
SRC,EGFR
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
RELA,AKR1B1
|
NADisease Category: NADisease ICD-11 Code: NA |
MET
NCT00217737 |
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
HSPA1A,HSPA1B
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
KDR,EGFR
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
F2,THPO
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
KDR,F2
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ACHE,MAOA
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
SRC,TEK
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
F2,THPO
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
F2
NCT00029679 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
INSR,RORC
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
F2,EGFR
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
RORC,RELA
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
SRC,EGFR
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT02777437,NCT03484195
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT00003549,NCT03167164
|
Intrahepatic cholangiocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.10 |
NCT03771846,NCT04961970
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT04241185,NCT02710734
|
Neoplasms of unknown behaviour of larynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F91.0 |
NCT00599131,NCT00117572
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT00204932,NCT02063802
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT03013218,NCT03169790
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT04011618,NCT02337933
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT03042780,NCT03736720
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
NCT00117572,NCT00117572
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00526110,NCT00208936
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT02879513,NCT01880385
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
SMAD3,ACHE
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
AKR1B1,TSHR
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
ACHE,MET
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
RORC,F2
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
F2,MET
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
FFAR1,ACHE
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
FFAR1,MET
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
THPO,ELAVL3
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
ACHE,MET
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT00953394,NCT03387592,NCT00003558,NCT03168607,NCT05015621,NCT02172976,NCT00001569,NCT04919226,NCT00022178,NCT03837977,NCT03092895,NCT01489566,NCT02246127,NCT02820857,NCT01524094,NCT03164382,NCT04325425,NCT01858025
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
RECQL,GALNT2,EGFR,HPGD,FFAR4,APEX1,MET,LMNA,TDP1,GSTP1,KDR,SRC,CSNK2A2,ALOX15,SMN1,FFAR1,POLH
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
F2,ALOX15,MET
NCT03281369,NCT00183911,NCT04510064,NCT04908566,NCT04523818,NCT04675983,NCT02625610,NCT01567618,NCT02545504,NCT02494583,NCT05268510,NCT03959293 |
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CSNK2A1,KDR,EGFR,POLB,HSPA1B,IGF1R,TEK,RORC,MET,RELA,HSPA1A,APEX1,GSTP1,SRC
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
NCT03110510,NCT03291899,NCT04722133,NCT01127555,NCT01494363,NCT01572324,NCT03778593,NCT03785873,NCT03524508,NCT00090025,NCT05052099,NCT04005339,NCT04217954 |
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
RECQL,LMNA,NUAK1,POLB,AKR1C3,TEK,ACHE,CES1,F2,FFAR4,GSTP1,FABP3,ALOX15,MET
|
Malignant neoplasms of anus or anal canalDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
NCT00003652,NCT00025090,NCT01324141,NCT00316888,NCT00003596,NCT02369939,NCT00324415,NCT02059499,NCT02402842,NCT01621217,NCT00423293,NCT00955240,NCT00068744
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
TDP1,GALNT2,POLB,HSD17B10,AKR1B1,RORC,TSHR,FFAR1,FFAR4,GSTP1,ELAVL3,ALOX15,MET
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
TSHR,HPGD,FFAR4,ELAVL3,APEX1,MET,TDP1,GSTP1,FABP3,RORC,ALOX15,CSNK2A1,POLH
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT01867892,NCT00463840,NCT01888978,NCT01523457,NCT05047991,NCT04161755,NCT03693677,NCT03484299,NCT00059826,NCT01488552,NCT00005870,NCT01688336,NCT00002955,NCT01489865,NCT01591733,NCT03504423,NCT02539537,NCT00424827,NCT00045747,NCT02551991,NCT03136406,NCT01560949,NCT03600623,NCT05360732,NCT02676349,NCT04897854,NCT02574663,NCT04672005,NCT04084496,NCT00601627,NCT03991962,NCT00089024,NCT05462496,NCT04431258,NCT02351219,NCT03941093,NCT04589234,NCT05251038,NCT02717091,NCT01632306,NCT01827553,NCT03586869,NCT05065801,NCT02021422,NCT00068575,NCT01821729,NCT00004003,NCT04807972,NCT00436267,NCT00002689,NCT00323583,NCT00049348,NCT01836432,NCT01992705,NCT03899636,NCT03329248,NCT01473303,NCT01494506,NCT01454180,NCT02506842,NCT04228601,NCT01485744,NCT04594772,NCT04089150,NCT01754623,NCT03883919,NCT00960284,NCT00786006,NCT00112658,NCT02352337,NCT00609765,NCT00026130,NCT02241551,NCT03760614,NCT01661088,NCT05466799,NCT01652976,NCT04324307,NCT02028806,NCT04371224,NCT00003018,NCT03563144,NCT03861702,NCT04769414,NCT00112697,NCT02405585,NCT03167112,NCT02923921,NCT00003216,NCT03487016,NCT00275119,NCT00058201,NCT04390399,NCT00003029,NCT00417976,NCT00010062,NCT00262951,NCT02311439,NCT00660270,NCT01063192,NCT03443492,NCT02355119,NCT02672917,NCT03336216,NCT02919787,NCT02581215,NCT00033735,NCT03563248,NCT00251355,NCT00602602,NCT01446458,NCT00005871,NCT02827201,NCT00024427,NCT00003049,NCT02128100,NCT00416507,NCT03387098,NCT03699319,NCT01905150,NCT00303758,NCT03042780
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NUAK1,AKR1B1,SMAD3,TEK,ACHE,HPGD,F2,SLC22A6,KDR,FABP3,MET,SMN1
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NUAK1,SRC,AKR1B1,IGF1R,GPR35,GSTP1,FABP3
NCT03017326,NCT00980460,NCT04478292,NCT00003994 |
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT02289768,NCT02281682,NCT02616601,NCT02019355,NCT00377273,NCT01525329,NCT05078827,NCT03037541,NCT04875026,NCT00696488,NCT01354717
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT01238965,NCT01871571,NCT01302613,NCT00235898,NCT02514278,NCT04130854,NCT00832299,NCT00025337,NCT00942266,NCT04423965,NCT00278694,NCT05108428,NCT02704520,NCT03781323,NCT05022030,NCT03043729,NCT01111604,NCT03300544,NCT01274962,NCT02423226,NCT00307736,NCT00422864,NCT01740648,NCT04418895,NCT05201430,NCT01376453,NCT00807911,NCT03161574,NCT03127007,NCT03000374,NCT02887313,NCT04495088,NCT00003799,NCT04009876,NCT03428529,NCT00145769,NCT01269229,NCT00101894,NCT02941562,NCT00052559,NCT03152370,NCT02217020,NCT05111860,NCT00321685,NCT03259035,NCT02280070,NCT03671252,NCT03443661,NCT00006094,NCT01270438,NCT00070122,NCT02270606,NCT02041481,NCT04165772,NCT02921256,NCT02167321,NCT03484221,NCT02574663,NCT00580073,NCT05358704,NCT01716949,NCT01554059,NCT02942563,NCT04838496,NCT01481545,NCT03391843,NCT03879109,NCT00527111,NCT02465593,NCT01197664,NCT00337389,NCT03085992,NCT00499369,NCT04380337,NCT01211210,NCT05024097,NCT05253846,NCT01013805,NCT05074966,NCT02008656,NCT01650428,NCT05412082,NCT04621370,NCT00707889,NCT02319304,NCT01500993,NCT04808323,NCT01060007,NCT05009069,NCT03548961,NCT01269216,NCT04215731,NCT01198548,NCT00349076,NCT00003873,NCT04170530,NCT02340949,NCT01347645,NCT01205022,NCT00611858,NCT00865189,NCT03299660,NCT05378919,NCT02688712,NCT03975049,NCT03921684,NCT00303628,NCT01941641
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
IGF1R,KDR,SRC,EGFR,MET,TEK
NCT00433420,NCT02393833,NCT00003012,NCT00014222,NCT04127019,NCT03387085,NCT01270373,NCT00152178,NCT01036087,NCT02115204,NCT00309569,NCT02897050,NCT00820547,NCT00015886,NCT01855828,NCT00499603,NCT02681003,NCT00002696,NCT00629278,NCT03175666,NCT00193011,NCT01358877,NCT00003680,NCT02115152,NCT00129922,NCT00776724,NCT00002870,NCT02846428,NCT02225652,NCT00002498,NCT00908791,NCT00002784,NCT00012311,NCT00010075,NCT00003577,NCT00152191,NCT01985724,NCT00003013,NCT00124111,NCT02132949,NCT00036868,NCT02400567,NCT01314833,NCT00002579,NCT02365805,NCT02897700,NCT01031030,NCT00055679,NCT02450058,NCT01966471,NCT00002581,NCT00002582,NCT00756470,NCT00005581,NCT00087178,NCT01204437,NCT02995772,NCT00002580,NCT01937507,NCT01216111,NCT00003086,NCT01222052,NCT01985841,NCT00002755,NCT00872625,NCT00311636,NCT04031703,NCT00002542,NCT01231802,NCT01593020,NCT00431080,NCT00003893,NCT00033683,NCT00630032,NCT00533936,NCT00017095,NCT00525759,NCT00950300,NCT00615602,NCT00001498,NCT00963729,NCT00054587,NCT00038402,NCT00625898,NCT02742051,NCT00336791,NCT00309478,NCT00688740,NCT00331097,NCT00559845,NCT00301925,NCT03888677,NCT02980965,NCT00773695,NCT00047099,NCT03554109,NCT00129389,NCT01642771,NCT00929591,NCT00053911 |
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
EGFR,IGF1R,MET,CSNK2A1,KDR
NCT00507585,NCT00238160,NCT00471484,NCT03092895,NCT03164382 |
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
LMNA,AKR1B1,SRC,SMAD3,CSNK2A1,NUAK1,IGF1R,GPR35,GSTP1,ELAVL3
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
Ocular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D00-2D07 |
APEX1
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
RELA
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
RELA
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
IGF1R
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
MAOA
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
ACHE
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
RELA
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
RELA
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TEK
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
SRC
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
MAOA
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
CES1
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
SRC
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
MAOA
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
EGFR
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
RORC
|
Coagulation defectDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B10 |
F2
|
Lysosomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C56 |
INSR
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
RELA
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
SRC
|
Type-1/2 diabeteDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10-5A11 |
INSR
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Coronary thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA43 |
F2
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Skin tag/polypDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK71 |
MAOA
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
RELA
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
F2
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
INSR
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RELA
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
IGF1R
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
F2
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
AKR1C3
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
RELA
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
MAOA
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F2
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FFAR1
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
AKR1B1
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
SRC
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
RELA
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
NCT02591030
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT01498783
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
NCT00455416
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00849264
|
Signet ring cell carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4546 |
NCT00217737
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00625092
|
Malignant neoplasms of other or unspecified parts of biliary tractDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT05350943
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003331
|
Squamous intraepithelial neoplasia, high gradeDisease Category: X.Extension CodesDisease ICD-11 Code: XH3EA2 |
NCT02059499
|
Malignant neoplasms of corpus uteriDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT00782041
|
Malignant neoplasms of nasal cavityDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C20 |
NCT00117572
|
Mucinous adenocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1S75 |
NCT00068692
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT02419495
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT01498783
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT02419495
|
skin carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C31.0-2E67.40 |
NCT02218164
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT02419495
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03323463
|
Chalazion, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.0Z |
NCT02025023
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT03216876
|
Malignant neoplasms of larynx, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C23.Z |
NCT00508664
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT02590367
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT00000758
|
Dysplastic naevusDisease Category: X.Extension CodesDisease ICD-11 Code: XH9035 |
NCT00346502
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT03197571
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00002524
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02419495
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT03541252
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
MAOA
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
HPGD
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
AKR1C3
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
AKR1B1
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
ALOX15
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
MET
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
AKR1C3
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
